TAŞ, F. Et Al. 2016. Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer. AMERICAN JOURNAL OF THERAPEUTICS , vol.23, no.3 .

TAŞ, F., YILDIZ, İ., Kilic, L., Ciftci, R., Keskin, S., & Sen, F., (2016). Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer. AMERICAN JOURNAL OF THERAPEUTICS , vol.23, no.3.

TAŞ, Faruk Et Al. "Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer," AMERICAN JOURNAL OF THERAPEUTICS , vol.23, no.3, 2016

TAŞ, Faruk Et Al. "Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer." AMERICAN JOURNAL OF THERAPEUTICS , vol.23, no.3, 2016

TAŞ, F. Et Al. (2016) . "Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer." AMERICAN JOURNAL OF THERAPEUTICS , vol.23, no.3.

@article{article, author={Faruk TAŞ Et Al. }, title={Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer}, journal={AMERICAN JOURNAL OF THERAPEUTICS}, year=2016}